FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3097469155> ?p ?o ?g. }

• W3097469155 endingPage "1349" @default.
• W3097469155 startingPage "1342" @default.
• W3097469155 abstract "There is a lack of evidence to guide treatment of comorbid depression and anxiety. Preliminary evidence suggests mirtazapine may be effective in treating patients with both depression and anxiety symptoms.We undertook a secondary analysis of mirtazapine (MIR): a placebo-controlled trial of the addition of mirtazapine to a selective serotonin reuptake inhibitor or serotonin-norepinephrine reuptake inhibitor in treatment-resistant depression (TRD) in primary care. We subdivided participants into three groups by baseline generalized anxiety disorder score (GAD-7): severe (GAD-7 ⩾ 16), moderate (GAD-7 = 11-15), no/mild (GAD-7 ⩽ 10). We used linear regression including likelihood-ratio testing of interaction terms to assess how baseline anxiety altered the response of participants to mirtazapine as measured by 12-week GAD-7 and Beck Depression Inventory II (BDI-II) scores.Baseline generalized anxiety moderated mirtazapine's effect as measured by GAD-7 (p = 0.041) and BDI-II (p = 0.088) at 12 weeks. Participants with severe generalized anxiety receiving mirtazapine had lower 12-week GAD-7 score (adjusted difference between means (ADM) -2.82, 95% confidence interval (CI) -0.69 to -4.95) and larger decreases in BDI-II score (ADM -6.36, 95% CI -1.60 to -10.84) than placebo. Conversely, there was no anxiolytic benefit (ADM 0.28, 95% CI -1.05 to 1.60) or antidepressant benefit (ADM -0.17, 95% CI -3.02 to 2.68) compared with placebo in those with no/mild generalized anxiety.These findings extend the evidence for the effectiveness of mirtazapine to reduce generalized anxiety in TRD in primary care. These results may inform targeted prescribing in depression based on concurrent anxiety symptoms, although these conclusions are constrained by the post-hoc nature of this analysis." @default.
• W3097469155 created "2020-11-09" @default.
• W3097469155 creator A5012491915 @default.
• W3097469155 creator A5019176918 @default.
• W3097469155 creator A5026519715 @default.
• W3097469155 creator A5027494774 @default.
• W3097469155 creator A5038573100 @default.
• W3097469155 creator A5044138661 @default.
• W3097469155 creator A5054449436 @default.
• W3097469155 creator A5055543220 @default.
• W3097469155 creator A5078660144 @default.
• W3097469155 creator A5079346001 @default.
• W3097469155 creator A5089102976 @default.
• W3097469155 date "2020-11-04" @default.
• W3097469155 modified "2023-10-13" @default.
• W3097469155 title "Does anxiety moderate the effectiveness of mirtazapine in patients with treatment-resistant depression? A secondary analysis of the MIR trial" @default.
• W3097469155 cites W1964640782 @default.
• W3097469155 cites W1972746899 @default.
• W3097469155 cites W1974450862 @default.
• W3097469155 cites W1975549116 @default.
• W3097469155 cites W1989299029 @default.
• W3097469155 cites W2028756415 @default.
• W3097469155 cites W2043705607 @default.
• W3097469155 cites W2069151316 @default.
• W3097469155 cites W2074130396 @default.
• W3097469155 cites W2111118992 @default.
• W3097469155 cites W2118070418 @default.
• W3097469155 cites W2128283668 @default.
• W3097469155 cites W2133315555 @default.
• W3097469155 cites W2135534575 @default.
• W3097469155 cites W2140107414 @default.
• W3097469155 cites W2163267194 @default.
• W3097469155 cites W2165907179 @default.
• W3097469155 cites W2254646458 @default.
• W3097469155 cites W2765822240 @default.
• W3097469155 cites W2885386535 @default.
• W3097469155 cites W2912280329 @default.
• W3097469155 cites W2930925342 @default.
• W3097469155 cites W2974841401 @default.
• W3097469155 cites W3080413193 @default.
• W3097469155 cites W4247665917 @default.
• W3097469155 cites W4313371589 @default.
• W3097469155 doi "https://doi.org/10.1177/0269881120965939" @default.
• W3097469155 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7708671" @default.
• W3097469155 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33143538" @default.
• W3097469155 hasPublicationYear "2020" @default.
• W3097469155 type Work @default.
• W3097469155 sameAs 3097469155 @default.
• W3097469155 citedByCount "2" @default.
• W3097469155 countsByYear W30974691552021 @default.
• W3097469155 countsByYear W30974691552022 @default.
• W3097469155 crossrefType "journal-article" @default.
• W3097469155 hasAuthorship W3097469155A5012491915 @default.
• W3097469155 hasAuthorship W3097469155A5019176918 @default.
• W3097469155 hasAuthorship W3097469155A5026519715 @default.
• W3097469155 hasAuthorship W3097469155A5027494774 @default.
• W3097469155 hasAuthorship W3097469155A5038573100 @default.
• W3097469155 hasAuthorship W3097469155A5044138661 @default.
• W3097469155 hasAuthorship W3097469155A5054449436 @default.
• W3097469155 hasAuthorship W3097469155A5055543220 @default.
• W3097469155 hasAuthorship W3097469155A5078660144 @default.
• W3097469155 hasAuthorship W3097469155A5079346001 @default.
• W3097469155 hasAuthorship W3097469155A5089102976 @default.
• W3097469155 hasBestOaLocation W30974691551 @default.
• W3097469155 hasConcept C118552586 @default.
• W3097469155 hasConcept C126322002 @default.
• W3097469155 hasConcept C139719470 @default.
• W3097469155 hasConcept C142724271 @default.
• W3097469155 hasConcept C15744967 @default.
• W3097469155 hasConcept C162324750 @default.
• W3097469155 hasConcept C168563851 @default.
• W3097469155 hasConcept C204787440 @default.
• W3097469155 hasConcept C27081682 @default.
• W3097469155 hasConcept C2776653193 @default.
• W3097469155 hasConcept C2776867660 @default.
• W3097469155 hasConcept C2779177272 @default.
• W3097469155 hasConcept C2779631380 @default.
• W3097469155 hasConcept C2779911313 @default.
• W3097469155 hasConcept C2780092697 @default.
• W3097469155 hasConcept C2781068410 @default.
• W3097469155 hasConcept C31487548 @default.
• W3097469155 hasConcept C558461103 @default.
• W3097469155 hasConcept C71924100 @default.
• W3097469155 hasConceptScore W3097469155C118552586 @default.
• W3097469155 hasConceptScore W3097469155C126322002 @default.
• W3097469155 hasConceptScore W3097469155C139719470 @default.
• W3097469155 hasConceptScore W3097469155C142724271 @default.
• W3097469155 hasConceptScore W3097469155C15744967 @default.
• W3097469155 hasConceptScore W3097469155C162324750 @default.
• W3097469155 hasConceptScore W3097469155C168563851 @default.
• W3097469155 hasConceptScore W3097469155C204787440 @default.
• W3097469155 hasConceptScore W3097469155C27081682 @default.
• W3097469155 hasConceptScore W3097469155C2776653193 @default.
• W3097469155 hasConceptScore W3097469155C2776867660 @default.
• W3097469155 hasConceptScore W3097469155C2779177272 @default.
• W3097469155 hasConceptScore W3097469155C2779631380 @default.
• W3097469155 hasConceptScore W3097469155C2779911313 @default.
• W3097469155 hasConceptScore W3097469155C2780092697 @default.

• next